Clinical Trials Browser

INDUSTRY × Neoplasms × Interleukin-18 × Clear all

NCT00500058 2017-07-26

A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18

Phase 1 Completed

Lymphoma, Non-Hodgkin, Neoplasms

NCT00085904 2008-10-13

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Phase 1 Completed

Lymphoma, Neoplasms